Summary
This is the 2021 ESC/EACTS guideline on valvular heart disease management, representing consensus clinical recommendations from the European Society of Cardiology and European Association for Cardio-Thoracic Surgery. The guideline synthesises scientific and medical evidence to inform health professionals' clinical judgement and implementation of preventive, diagnostic, and therapeutic strategies. It emphasises that whilst guidelines should inform clinical practice, individual health professionals retain responsibility for patient-centred care decisions in consultation with patients.
UK applicability
These ESC guidelines are widely adopted or closely aligned with UK clinical practice through NICE and British Cardiovascular Society recommendations. UK health professionals would reference these guidelines as part of contemporary evidence-based practice for valvular heart disease management.
Key measures
Not applicable—this is a clinical guideline document rather than an empirical study with specific quantitative metrics
Outcomes reported
The document provides evidence-based clinical guidelines for the diagnosis, management, and treatment of patients with valvular heart disease. It addresses preventive, diagnostic, and therapeutic medical strategies informed by scientific evidence available at the time of publication.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.